Last updated on January 2019

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

Brief description of study

The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy discontinuation criteria in a prior Gilead-sponsored filgotinib treatment study in ulcerative colitis (UC).

Clinical Study Identifier: NCT02914535

Contact Investigators or Research Sites near you

Start Over

Gilead Clinical Study Information Center

Florida Medical Clinic, P.A.
Zephyrhills, FL United States

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.